Reckitt Benckiser

Finsbury is working media for Reckitt Benckiser Group’s record $1.4B opioid-linked settlement with the Justice Dept. and Federal Trade Commission regarding marketing practices for the Suboxone Film painkiller of its former subsidiary, Indivior.

Though UK-based RB maintains it did nothing wrong, the board opted to make peace with feds in the best interests of the company and shareholders.

The settlement “avoids the costs, uncertainty and distraction associated with continued investigations, litigation and the potential of an indictment at a time of significant transformation under RB 2.0 and during CEO transition,” said RB’s statement.

Laxman Narasimhan, who was chief commercial officer at PepsiCo, will succeed Rakesh Kapoor at the helm of the pharmaceuticals, personal care and “home hygiene” (Air Wick, Lysol, Calgon, Woolite, Vanish) company on Sept. 1.

RB “demerged” Indivior in 2014.

Finsbury’s Faeth Birch and Philip Walters rep RB.